Literature DB >> 9095625

Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy.

K Kamada1, K Houkin, H Abe, Y Sawamura, T Kashiwaba.   

Abstract

Proton magnetic resonance spectroscopy (1H MRS) was evaluated for distinguishing between radiation necrosis and recurrent glioma in 11 patients after high-dose radiotherapy. Six patients had a histological diagnosis of recurrent glioma. Four patients had a histological diagnosis of radiation necrosis and one had a clinical course consistent with the diagnosis of radiation necrosis. 1H MRS showed cases of radiation necrosis had two characteristic 1H MRS patterns: markedly increased lactate/creatine and phosphocreatine (Cr) ratio and decreased choline-containing compounds/Cr ratio compared to that of recurrent glioma; or all the major metabolites were completely diminished. The N-acetyl aspartate signal was not helpful for differential diagnosis. 1H MRS is a potentially useful method for differentiating tumor recurrence from radiation necrosis in patients treated for malignant glioma.

Entities:  

Mesh:

Year:  1997        PMID: 9095625     DOI: 10.2176/nmc.37.250

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  22 in total

1.  Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Ramon F Barajas; Jamie S Chang; Mark R Segal; Andrew T Parsa; Michael W McDermott; Mitchel S Berger; Soonmee Cha
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

Review 2.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

3.  Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.

Authors:  Mikhail F Chernov; Motohiro Hayashi; Masahiro Izawa; Yuko Ono; Tomokatsu Hori
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

4.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

5.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Authors:  Fumiyuki Yamasaki; Kaoru Kurisu; Yoshinori Kajiwara; Yosuke Watanabe; Takeshi Takayasu; Yuji Akiyama; Taiichi Saito; Ryosuke Hanaya; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

6.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

Authors:  H P Schlemmer; P Bachert; K K Herfarth; I Zuna; J Debus; G van Kaick
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 8.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

Review 9.  Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Kendall Kiser; Lisanne van Dijk; Nadia Roxanne Livingstone; Hesham Elhalawani; Baher Elgohari; Brigid McDonald; Juan Ventura; Abdallah Sherif Radwan Mohamed; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-10-31       Impact factor: 3.722

Review 10.  The role of brachytherapy in the treatment of glioblastoma multiforme.

Authors:  Eric Barbarite; Justin T Sick; Emmanuel Berchmans; Amade Bregy; Ashish H Shah; Nagy Elsayyad; Ricardo J Komotar
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.